Drug Profile
BP 3181
Latest Information Update: 27 Nov 1995
Price :
$50
*
At a glance
- Originator Bioprojet
- Class Antihistamines
- Mechanism of Action Histamine H3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 27 Nov 1995 No-Development-Reported for CNS disorders in France (Unknown route)